medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2021, Number S1

<< Back Next >>

Acta Med 2021; 19 (S1)

Telemedicine in times of pandemic

Trejo CAI, Carrión ?D, Salas AJC

Language: Spanish
References: 27
Page: s80-83
PDF size: 136.51 Kb.


ABSTRACT

The purpose of this article is to analyse the advantages and disadvantages in telemedicine during the pandemic. We conducted a systematic review in Web of Science with the keywords "COVID-19 and Dermatology and Telemedicine" and "Telemedicine and Dermatology and Pandemic". From 11 articles we included nine. We found in some papers that more than 70% of the physical consultation could be substituted by telemedicine, as well as the resistance from patients in the use of such tool (WellMedic). Telemedicine is a tool that possesses relevant advantages in times of crisis, reducing the risk of exposition for patients and health providers and better distribution of the personal protection equipment. However, it has technical limitations in developing countries or rural areas, as well as the resistance from patients and doctors to use it. Furthermore, there is a lack of legal regulations in some countries. However, the cost-benefit has proven to be superior. This is the first article that talks about telemedicine in Mexico during this pandemic and its impact.


REFERENCES

  1. Hurst EJ. Evolutions in telemedicine: from smoke signals to mobile health solutions. J Hosp Librariansh. 2016; 16 (2): 174-185. Available from: http://www.tandfonline.com/doi/full/10.1080/15323269.2016.1150750

  2. National Library of Medicine. (1993). Telemedicine. https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Telemedicine%22%5BMeSH+Terms%5D

  3. Moore M. The evolution of telemedicine. Futur Gener Comput Syst. 1999; 15 (2): 245-254. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167739X98000673

  4. Jin Z, Chen Y. Telemedicine in the cloud era: prospects and challenges. IEEE Pervasive Comput. 2015; 14 (1): 54-61. Available from: http://ieeexplore.ieee.org/document/7030248/

  5. Elliott T, Yopes MC. Direct-to-consumer telemedicine. J Allergy Clin Immunol Pract. 2019; 7 (8): 2546-2452. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213219819305999

  6. Jain T, Lu RJ, Mehrotra A. Prescriptions on demand: the growth of direct-to-consumer telemedicine companies. JAMA. 2019; 322 (10): 925. Available from: https://jamanetwork.com/journals/jama/fullarticle/2740743

  7. Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M et al. Telemedicine in neurology: telemedicine work group of the American Academy of Neurology update. Neurology. 2020; 94 (1): 30-38. Available from: http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000008708

  8. Dahy A, El-Qushayri AE, Mahmoud AR, Al-kelany TA, Salman S. Telemedicine approach for psoriasis management, time for application? A systematic review of published studies. Dermatol Thert. 2020; Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/dth.13908

  9. Makhni MC, Riew GJ, Sumathipala MG. Telemedicine in orthopaedic surgery. J Bone Jt Surg [Internet]. 2020; Publish Ah. Available from: https://journals.lww.com/10.2106/JBJS.20.00452

  10. Iancu AM, Kemp MT, Alam HB. Unmuting medical students' education: utilizing telemedicine during the COVID-19 pandemic and beyond. J Med Internet Res. 2020; 22 (7): e19667. Available from: http://www.jmir.org/2020/7/e19667/

  11. Arimany-Manso J, Pujol RM, García-Patos V, Saigí U, Martin-Fumadó C. Aspectos médico-legales de la teledermatología. Actas Dermosifiliogr. 2020; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0001731020303136

  12. Mehrotra A, Huskamp HA, Souza J, Uscher-Pines L, Rose S, Landon BE, et al. Rapid growth in mental health telemedicine use among rural medicare beneficiaries, wide variation across states. Health Aff. 2017; 36 (5): 909-917. Available from: http://www.healthaffairs.org/doi/10.1377/hlthaff.2016.1461

  13. Menage J. Why telemedicine diminishes the doctor-patient relationship. BMJ. 2020; m4348. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.m4348

  14. Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Informatics Assoc. 2020; 27 (7): 1132-1135. Available from: https://academic.oup.com/jamia/article/27/7/1132/5824298

  15. Perkins S, Cohen JM, Nelson CA, Bunick CG. Teledermatology in the era of COVID-19: experience of an academic department of dermatology. J Am Acad Dermatol. 2020; 83 (1): e43-44. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0190962220306617

  16. Adisen E, Afacan E, Gürer MA. Not the pandemic but telemedicine will prevent dermatology patients from overloading the healthcare system. Dermatol Ther [Internet]. 2020; 1-5. Available from: https://onlinelibrary.wiley.com/doi/10.1111/dth.14302

  17. Kazi R, Evankovich MR, Liu R, Liu A, Moorhead A, Ferris LK et al. Utilization of asynchronous and synchronous teledermatology in a large health care system during the COVID-19 pandemic. Telemed e-Health. 2020. Available from: https://www.liebertpub.com/doi/10.1089/tmj.2020.0299

  18. Luz PL da. Telemedicine and the doctor/patient relationship. Arq Bras Cardiol. 2019; 113 (1). Available from: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000700100

  19. Stokel-Walker C. Why telemedicine is here to stay. BMJ. 2020; m3603. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.m3603

  20. Gomolin T, Cline A, Handler MZ. The danger of neglecting melanoma during the COVID-19 pandemic. J Dermatolog Treat. 2020; 31 (5): 444-445. Available from: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1762844

  21. Rismiller K, Cartron AM, Trinidad JCL. Inpatient teledermatology during the COVID-19 pandemic. J Dermatolog Treat. 2020; 31 (5): 441-443. Available from: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1762843

  22. Trinidad J, Kroshinsky D, Kaffenberger BH, Rojek NW. Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic. J Am Acad Dermatol. 2020; 83 (1): e69-71. Available from: https://doi.org/10.1016/j.jaad.2020.04.096

  23. Beer J, Abrouk M, Kirsner R. Telemedicine platforms used in academic dermatology during the COVID-19 pandemic: implications for adaptation and usage. J Drugs Dermatology. 2020; 19 (8): 797-798. Available from: https://jddonline.com/articles/dermatology/S1545961620P0797X

  24. Hammond MI, Sharma TR, Cooper KD, Beveridge MG. Conducting inpatient dermatology consultations and maintaining resident education in the COVID-19 telemedicine era. J Am Acad Dermatol. 2020; 83 (4): e317-318. Available from: https://doi.org/10.1016/j.jaad.2020.07.008

  25. Kumar S, Bishnoi A, Vinay K. Changing paradigms of dermatology practice in developing nations in the shadow of COVID-19: lessons learnt from the pandemic. Dermatol Ther. 2020; 33 (4): 3-5. Available from: https://onlinelibrary.wiley.com/doi/10.1111/dth.13472

  26. Abi Rafeh J, Cattelan L, Zargham H, Jafarian F. Growing role of telemedicine in dermatology: a practical, timely application for skin cancer screening in organ transplant recipients. J Cutan Med Surg. 2020; 120347542095762. Available from: https://doi.org/10.1177/1203475420957626

  27. Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020; 382 (18): 1679-1681. Available from: http://www.nejm.org/doi/10.1056/NEJMp2003539




2020     |     www.medigraphic.com